M. Halank
- Bosentan therapy for portopulmonary hypertensionBy M. M. Hoeper, M. Halank, C. Marx, G. Hoeffken, H. J. Seyfarth, J. Schauer, J. Niedermeyer and J. WinklerM. M. HoeperM. HalankC. MarxG. HoeffkenH. J. SeyfarthJ. SchauerJ. Niedermeyer
- High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusionsBy M. Kolditz, M. Halank, C. S. Schiemanck, A. Schmeisser and G. HöffkenM. KolditzM. HalankC. S. SchiemanckA. Schmeisser
- Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertensionBy M. M. Hoeper, H. Leuchte, M. Halank, H. Wilkens, F. J. Meyer, H. J. Seyfarth, R. Wensel, F. Ripken, H. Bremer, S. Kluge, G. Hoeffken and J. BehrM. M. HoeperH. LeuchteM. HalankH. WilkensF. J. MeyerH. J. SeyfarthR. WenselF. RipkenH. BremerS. KlugeG. Hoeffken
- Experience with inhaled iloprost and bosentan in portopulmonary hypertensionBy M. M. Hoeper, H. J. Seyfarth, G. Hoeffken, H. Wirtz, E. Spiekerkoetter, M. W. Pletz, T. Welte and M. HalankM. M. HoeperH. J. SeyfarthG. HoeffkenH. WirtzE. SpiekerkoetterM. W. PletzT. Welte
- Long-term outcome with intravenous iloprost in pulmonary arterial hypertensionBy M. M. Hoeper, H. Gall, H. J. Seyfarth, M. Halank, H. A. Ghofrani, J. Winkler, H. Golpon, K. M. Olsson, N. Nickel, C. Opitz and R. EwertM. M. HoeperH. GallH. J. SeyfarthM. HalankH. A. GhofraniJ. WinklerH. GolponK. M. OlssonN. NickelC. Opitz
- Adrenal function is related to prognosis in moderate community-acquired pneumoniaBy M. Kolditz, M. Halank, B. Schulte-Hubbert and G. HöffkenM. KolditzM. HalankB. Schulte-Hubbert
- Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II studyBy H.A. Ghofrani, M.M. Hoeper, M. Halank, F.J. Meyer, G. Staehler, J. Behr, R. Ewert, G. Weimann and F. GrimmingerH.A. GhofraniM.M. HoeperM. HalankF.J. MeyerG. StaehlerJ. BehrR. EwertG. Weimann
- High-flow oxygen therapy in COPD patients: Optimised oxygen deliveryBy Helene Vogelsinger, M. Halank, H. Wilkens, T. Geiser, S. Braun, S. Ott, A. Stucki and C.M. KaehlerHelene Vogelsinger1Internal Medicine, Pneumology, Internal Medicine VI, Medical University of Innsbruck, Innsbruck, AustriaM. Halank2Pneumologie, Medizinische Klinik Und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Dresden, GermanyH. Wilkens3Pneumologie, Universitätsklinikum Des Saarlandes, Homburg, GermanyT. Geiser4Klinik Und Poliklinik Für Pneumologie, Inselspital, Universitätsspital Bern, Bern, SwitzerlandS. Braun2Pneumologie, Medizinische Klinik Und Poliklinik I, University Hospital Carl Gustav Carus Dresden, Dresden, GermanyS. Ott4Klinik Und Poliklinik Für Pneumologie, Inselspital, Universitätsspital Bern, Bern, SwitzerlandA. Stucki5Berner REHA Zentrum, Berner REHA Zentrum, Heiligenschwendi, SwitzerlandC.M. Kaehler1Internal Medicine, Pneumology, Internal Medicine VI, Medical University of Innsbruck, Innsbruck, Austria
- High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusionsBy M. Kolditz, M. Halank, S. Schiemanck, A. Schmeisser and G. HöffkenArticle | Published in 2006 in European Respiratory JournalM. KolditzM. HalankS. SchiemanckA. Schmeisser
- Experience with inhaled iloprost and bosentan in portopulmonary hypertensionBy M.M. Hoeper, H.J. Seyfarth, G. Hoeffken, H. Wirtz, E. Spiekerkoetter, M.W. Pletz, T. Welte and M. HalankArticle | Published in 2007 in European Respiratory JournalM.M. HoeperH.J. SeyfarthG. HoeffkenH. WirtzE. SpiekerkoetterM.W. PletzT. Welte
- Long-term outcome with intravenous iloprost in pulmonary arterial hypertensionBy M.M. Hoeper, H. Gall, H.J. Seyfarth, M. Halank, H.A. Ghofrani, J. Winkler, H. Golpon, K.M. Olsson, N. Nickel, C. Opitz and R. EwertArticle | Published in 2009 in European Respiratory JournalM.M. HoeperH. GallH.J. SeyfarthM. HalankH.A. GhofraniJ. WinklerH. GolponK.M. OlssonN. NickelC. Opitz
- Adrenal function is related to the prognosis in moderate community-acquired pneumoniaBy M. Kolditz, M. Halank, B. Schulte-Hubbert and G. HöffkenArticle | Published in 2010 in European Respiratory JournalM. KolditzM. HalankB. Schulte-Hubbert
- Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II studyBy H.A. Ghofrani, M.M. Hoeper, M. Halank, F.J. Meyer, G. Staehler, J. Behr, R. Ewert, G. Weimann and F. GrimmingerArticle | Published in 2010 in European Respiratory JournalH.A. GhofraniM.M. HoeperM. HalankF.J. MeyerG. StaehlerJ. BehrR. EwertG. Weimann
- Safety and Efficacy of Exercise Training in various forms of Pulmonary HypertensionBy E. Grünig, M. Lichtblau, N. Ehlken, H.A. Ghofrani, F. Reichenberger, G. Staehler, M. Halank, C. Fischer, H-J. Seyfarth, H. Klose, A. Meyer, S. Sorichter, H. Wilkens, S. Rosenkranz, C. Opitz, H. Leuchte, G. Karger, R. Speich and C. NagelArticle | Published in 2012 in European Respiratory JournalE. GrünigM. LichtblauN. EhlkenH.A. GhofraniF. ReichenbergerG. StaehlerM. HalankC. FischerH-J. SeyfarthH. KloseA. MeyerS. SorichterH. WilkensS. RosenkranzC. OpitzH. LeuchteG. KargerR. Speich
- Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trialBy M.M. Hoeper, M. Halank, H. Wilkens, A. Günther, G. Weimann, I. Gebert, H. Leuchte and J. BehrArticle | Published in 2012 in European Respiratory JournalM.M. Hoeper*Dept of Respiratory Medicine, Hannover Medical School, Hannover, GermanyM. Halank#Dept of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, GermanyH. Wilkens¶Dept of Internal Medicine II, University of the Saarland, Homburg, GermanyA. Günther+Dept of Internal Medicine, Giessen University, Giessen, GermanyG. Weimann§BayerHealthCare AG, Pharma Research Centre, Wuppertal, GermanyI. GebertfBayer HealthCare, Bayer Vital GmbH, Pharma Medical Dept, Leverkusen, GermanyH. Leuchte**Dept of Internal Medicine I, Grosshadern Clinic, Ludwig Maximilian University of Munich, Munich, GermanyJ. Behr##Dept of Internal Medicine III, University Hospital Bergmannsheil, Bochum, Germany
- Outcome of non-cardiac, non-obstetric surgery in patients with pulmonary arterial hypertension: results from an international prospective surveyBy S. Meyer, V.V. McLaughlin, H.J. Seyfarth, T. M. Bull, C.D Vizza, M. Gomberg-Maitland, I. R. Preston, J.A. Barberà, P. M. Hassoun, M. Halank, X. Jaïs, Nils Nickel, Marius M. Hoeper and M. HumbertArticle | Published in 2012 in European Respiratory JournalS. Meyer*Hannover Medical School, Hannover, GermanyV.V. McLaughlin#University of Michigan Health System, Ann Arbor, MichiganH.J. Seyfarth¶University of Leipzig, GermanyT. M. Bull+University of Colorado Denver, Denver, ColoradoC.D Vizza§University of Rome La Sapienza, ItalyM. Gomberg-MaitlandfUniversity of Chicago, IllinoisI. R. Preston**Tufts University School of Medicine, MassachusettsJ.A. Barberà##Hospital Clínic, CIBERES, University of Barcelona, SpainP. M. Hassoun¶¶Johns Hopkins Medical University, Baltimore, MarylandM. Halank++University of Dresden, GermanyX. Jaïs§§Univ. Paris-Sud, APHP, Inserm UMR_S 999, Le Kremlin-Bicêtre, FranceNils Nickel*Hannover Medical School, Hannover, GermanyMarius M. Hoeper*Hannover Medical School, Hannover, GermanyM. Humbert§§Univ. Paris-Sud, APHP, Inserm UMR_S 999, Le Kremlin-Bicêtre, France
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.